Imipenem/Cilastatin
- 1 October 1984
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 3 (5) , 453-455
- https://doi.org/10.1007/bf02017374
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactamEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Susceptibility ofLegionella spp. to imipenem and 27 other beta-lactam antibioticsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- In vitro activity of imipenem — A reviewEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Imipenem versus moxalactam in the treatment of serious infectionsAntimicrobial Agents and Chemotherapy, 1983
- Occurrence and expression of imipemide (N-formimidoyl thienamycin) resistance in clinical isolates of coagulase-negative staphylococciAntimicrobial Agents and Chemotherapy, 1983
- Susceptibility of anaerobic bacteria to imipenemJournal of Antimicrobial Chemotherapy, 1983
- Thienamycin: development of imipenem-cilastatinJournal of Antimicrobial Chemotherapy, 1983
- Pharmacokinetic and bacteriological correlations between antimicrobial therapy of experimental meningitis in rabbits and meningitis in humans: a reviewJournal of Antimicrobial Chemotherapy, 1983
- Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococciAntimicrobial Agents and Chemotherapy, 1982
- In-vitro activity of MK0787 (N-formimidoyl thienamycin) against Pseudomonas aeruginosa and other Gram-negative organisms and its stability to their β-lactamasesJournal of Antimicrobial Chemotherapy, 1981